Related Experiment Video
Updated: Jul 31, 2026

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
Coma as an acute presentation of adrenoleukodystrophy
S Ravid1, A S Diamond, L Eviatar
1Division of Pediatric Neurology, Schneider Children's Hospital, New Hyde Park, New York, USA.
X-linked adrenoleukodystrophy (X-ALD) can present atypically, mimicking septic shock in children. Early diagnosis of this metabolic disorder is crucial to prevent irreversible damage.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- X-linked adrenoleukodystrophy (X-ALD) is a rare metabolic disorder affecting the adrenal glands and nervous system.
- It is characterized by impaired very-long-chain fatty acid metabolism, leading to accumulation in tissues.
- Clinical manifestations of X-ALD exhibit significant variability, complicating diagnosis.
Observation:
- A 4-year-old male presented with fever, hypotension, and coma, initially suspected as septic shock.
- Rapidly progressing disseminated intravascular coagulopathy and multiorgan failure were noted.
- Distinctive bronze skin pigmentation and posterior demyelination on cranial CT scan suggested X-ALD.
Findings:
- Elevated very-long-chain fatty acid (VLCFA) levels in plasma confirmed the diagnosis.
- An increased C24/C16 ratio in plasma and fibroblast cultures further supported the X-ALD diagnosis.
- Biochemical markers confirmed the metabolic defect characteristic of X-ALD.
Implications:
- Atypical presentations of X-ALD necessitate a high index of suspicion for timely diagnosis.
- Early detection and intervention are critical to mitigate severe neurological damage and multiorgan failure.
- Recognizing unusual symptoms can lead to earlier treatment initiation, improving patient outcomes in X-ALD.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Acute Pancreatitis II: Clinical Manifestations and Management
Cryptococcal Meningitis
Multiple Sclerosis l: Introduction
Alzheimer Disease l: Introduction
Dementia l: Introduction

